Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study

BackgroundMesenchymal Consensus Molecular Subtype 4 (CMS4) colon cancer is associated with poor prognosis and therapy resistance. In this proof-of-concept study, we assessed whether a rationally chosen drug could mitigate the distinguishing molecular features of primary CMS4 colon cancer.MethodsIn t...

Full description

Bibliographic Details
Main Authors:	Niek A. Peters, Alexander Constantinides, Inge Ubink, Joyce van Kuik, Haiko J. Bloemendal, Joyce M. van Dodewaard, Menno A. Brink, Thijs P. Schwartz, Martijn P.J.K. Lolkema, Miangela M. Lacle, Leon M. Moons, Joost Geesing, Wilhelmina M.U. van Grevenstein, Jeanine M. L. Roodhart, Miriam Koopman, Sjoerd G. Elias, Inne H.M. Borel Rinkes, Onno Kranenburg
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Oncology
Subjects:	colorectal cancer consensus molecular subtype 4 imatinib ImPACCT platelet-derived growth factor receptor (PDGFR)
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.969855/full

Similar Items

ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
by: Lizet M van der Waals, et al.
Published: (2018-01-01)

Paired image‐ and FACS‐based toxicity assays for high content screening of spheroid‐type tumor cell cultures
by: Kari Trumpi, et al.
Published: (2015-01-01)

Adequate symptom relief justifies hepatic resection for benign disease
by: van Hillegersberg Richard, et al.
Published: (2005-04-01)

Differential cytokine and chemokine expression after ablation vs. resection in colorectal cancer liver metastasis
by: Nicola Frenkel, et al.
Published: (2024-03-01)

Response to Letter to the Editor on Robotic Distal Pancreatectomy, a Novel Standard of Care? Benchmark Values for Surgical Outcomes From 16 International Expert Centers
by: Philip C. Müller, MD, et al.
Published: (2023-03-01)

Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
by: Onno Kranenburg, et al.
Published: (2022-12-01)

Loss of Neuropilin-2 in Murine Mesenchymal-like Colon Cancer Organoids Causes Mesenchymal-to-Epithelial Transition and an Acquired Dependency on Insulin-Receptor Signaling and Autophagy
by: Susanna Poghosyan, et al.
Published: (2022-01-01)

Detection of Experimental Colorectal Peritoneal Metastases by a Novel PDGFRβ-Targeting Nanobody
by: Esther Strating, et al.
Published: (2022-09-01)

Liver lymphatic drainage patterns follow segmental anatomy in a murine model
by: Nicola C. Frenkel, et al.
Published: (2020-12-01)

90Y-/166Ho- ‘Radiation lobectomy’ for liver tumors induces abnormal morphology and impaired drainage of peritumor lymphatics
by: Daan Andel, et al.
Published: (2024-02-01)

Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy
by: Lips Cornelis JM, et al.
Published: (2006-06-01)

Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)
by: I. Ubink, et al.
Published: (2017-04-01)

Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β
by: Lingli Zhou, et al.
Published: (2018-07-01)

Tissue clearing and immunostaining to visualize the spatial organization of vasculature and tumor cells in mouse liver
by: Nicola Frenkel, et al.
Published: (2023-03-01)

Long-Term Functional Recovery of Hepatocytes after Cryopreservation in a Three-Dimensional Culture Configuration
by: Inne H.M. Borel Rinkes, et al.
Published: (1992-07-01)

Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm
by: Vanessa Fiorini Furtado, et al.
Published: (2018-10-01)

Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma
by: Pender A, et al.
Published: (2017-12-01)

Oncogenic KRAS Desensitizes Colorectal Tumor Cells to Epidermal Growth Factor Receptor Inhibition and Activation
by: Winan J. van Houdt, et al.
Published: (2010-06-01)

Mode of progression after radioembolization in patients with colorectal cancer liver metastases
by: Caren van Roekel, et al.
Published: (2020-09-01)

Hepatic Radioembolization as a Bridge to Liver Surgery
by: Arthur J.A.T. Braat, et al.
Published: (2014-07-01)

External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort
by: Karen Bolhuis, et al.
Published: (2022-05-01)

Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
by: Esther Strating, et al.
Published: (2023-05-01)

Breast MRI in nonpalpable breast lesions: a randomized trial with diagnostic and therapeutic outcome – MONET – study
by: de Boer Erwin, et al.
Published: (2007-11-01)

Outcomes of Minimally Invasive Thyroid Surgery – A Systematic Review and Meta-Analysis
by: Lisa H. de Vries, et al.
Published: (2021-08-01)

EVENTOS DE SEÑALIZACIÓN ASOCIADOS AL FACTOR DE CRECIMIENTO DERIVADO DE PLAQUETAS (PDGF)
by: L. Morales-Álvarez, et al.
Published: (2005-12-01)

PDGFRB Promotes Liver Metastasis Formation of Mesenchymal-Like Colorectal Tumor Cells
by: Ernst J.A. Steller, et al.
Published: (2013-02-01)

External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice
by: Patricia A. H. Hamers, et al.
Published: (2022-10-01)

Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes
by: Stefania Stella, et al.
Published: (2021-01-01)

Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
by: Simone Romagnoli, et al.
Published: (2021-11-01)

The efficacy of 'Radio guided Occult Lesion Localization' (ROLL) versus 'Wire-guided Localization' (WGL) in breast conserving surgery for non-palpable breast cancer: A randomized clinical trial – ROLL study
by: Mali Willem PTHM, et al.
Published: (2008-05-01)

Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma
by: Paula Aldaz, et al.
Published: (2021-01-01)

The effect of a density gradient in groundwater on ATES system efficiency and subsurface space use
by: M. Bloemendal, et al.
Published: (2018-08-01)

M2 Macrophages Promote PDGFRβ+ Pericytes Migration After Spinal Cord Injury in Mice via PDGFB/PDGFRβ Pathway
by: Ziyu Li, et al.
Published: (2021-04-01)

Manufacturers’ views on outcome-based agreements
by: Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, et al.
Published: (2021-01-01)

PDGF-induced cell motility depends on EDG-1
by: Terry Peter, et al.
Published: (2001-03-01)

Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis
by: Eva M Buhl, et al.
Published: (2020-03-01)

Development of Radiogallium-Labeled Peptides for Platelet-Derived Growth Factor Receptor <i>β</i> (PDGFR<i>β</i>) Imaging: Influence of Different Linkers
by: Nurmaya Effendi, et al.
Published: (2020-12-01)

Imatinib Sets Pericyte Mosaic in the Retina
by: Tamás Kovács-Öller, et al.
Published: (2020-04-01)

Syndecan Transmembrane Domain Specifically Regulates Downstream Signaling Events of the Transmembrane Receptor Cytoplasmic Domain
by: Jisun Hwang, et al.
Published: (2021-07-01)

Research progress on the role of PDGF/PDGFR in type 2 diabetes
by: Zhanqi Cao, et al.
Published: (2023-08-01)